Effects of lepirudin, argatroban and melagatran and additional influence of phenprocoumon on ecarin clotting time

By Fenyvesi T.   Jorg I.   Weiss C.   Harenberg J.  

Thrombosis Research, Vol. 111, Iss. 1, 2003-01 ,pp. : 89-94

Elsevier

Access to resources Recommend Favorite

IN VITRO STUDIES ON THE EFFECT OF ACTIVATED PROTEIN C ON PLATELET ACTIVATION AND THROMBIN GENERATION

By Kaiser B.   Jeske W.   Hoppensteadt D.H.   Walenga J.M.   Drohan W.   Fareed J.  

Thrombosis Research, Vol. 87, Iss. 2, 1997-07 ,pp. : 197-204

Elsevier

Access to resources Recommend Favorite

In vitro effect of a thrombin inhibition peptide selected by phage display technology

By Meiring M.S.   Litthauer D.   van Wyk V.   Badenhorst P.N.   Kotze H.F.  

Thrombosis Research, Vol. 107, Iss. 6, 2002-09 ,pp. : 365-371

Elsevier

Access to resources Recommend Favorite

Effect of Different Types of Thrombin Inhibitors on Thrombin/Thrombomodulin Modulated Activation of Protein C In Vitro

By Mattsson C.   Menschik-Lundin A.   Nylander S.   Gyzander E.   Deinum J.  

Thrombosis Research, Vol. 104, Iss. 6, 2001-12 ,pp. : 475-486

Elsevier

Access to resources Recommend Favorite

Drotrecogin Alfa (activated, Xigris®) in Combination with Heparin or Melagatran: An In vitro Investigation

By Koestenberger Martin   Cvirn Gerhard   Gallistl Siegfried   Baier Katrin   Leschnik Bettina   Muntean Wolfgang  

Journal of Thrombosis and Thrombolysis, Vol. 18, Iss. 1, 2004-08 ,pp. : 5-10

Springer Publishing Company

Access to resources Recommend Favorite